BridgeMD
New treatment option for Migraine Disorders
Official title MMA Embolization for Refractory Chronic Migraine
ClinicalTrials.gov ID: NCT06735833
What this study is testing
- What it's testing
- This is a prospective, multi-center, feasibility study to investigate safety and effectiveness of TRUFILL n-BCA liquid embolic system in bilateral middle meningeal artery (MMA) embolization for the treatment of refractory chronic migraine.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Participant , Candidates for this study must meet ALL the following
- Patient is between 18 and 65 years of age (inclusive) at the time of consent
- Age of onset of Chronic Migraine \<= 64 years
- Age of onset of migraine diagnosis \< 50 years
- Patient has a current diagnosis of refractory migraine
You likely can't join if
- , Candidates will be excluded from participation if ANY of the following apply:
- Patients with a history for the last 2 years of other primary headache types, or secondary headache types except medication overuse headache
- Patients with diagnosis of hemiplegic migraine or migrainous infarct
- Patients with current regular use of Opioids, Cannabis, Medical Marijuana, etc
- Women who are pregnant, lactating, or who are of childbearing age
- Current involvement in an investigational (drug, device, etc.) clinical trial that may confound study endpoints. Participants in observational...
See the full eligibility criteria
- Participant , Candidates for this study must meet ALL the following
- Patient is between 18 and 65 years of age (inclusive) at the time of consent
- Age of onset of Chronic Migraine \<= 64 years
- Age of onset of migraine diagnosis \< 50 years
- Patient has a current diagnosis of refractory migraine
- Patient has a current diagnosis of Chronic migraine Participant
- , Candidates will be excluded from participation if ANY of the following apply:
- Patients with a history for the last 2 years of other primary headache types, or secondary headache types except medication overuse headache
- Patients with diagnosis of hemiplegic migraine or migrainous infarct
- Patients with current regular use of Opioids, Cannabis, Medical Marijuana, etc
- Women who are pregnant, lactating, or who are of childbearing age
- Current involvement in an investigational (drug, device, etc.) clinical trial that may confound study endpoints. Participants in observational, natural history, and/or epidemiological studies not involving intervention...
The study team makes the final eligibility decision.
Where it's taking place
- Phoenix, Arizona, United States
- Walnut Creek, California, United States
- Hartford, Connecticut, United States
- Buffalo, New York, United States
- New York, New York, United States
- Stony Brook, New York, United States
- Philadelphia, Pennsylvania, United States
- Memphis, Tennessee, United States
- Morgantown, West Virginia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Phoenix, Arizona, United States; Walnut Creek, California, United States; Hartford, Connecticut, United States; Buffalo, New York, United States; New York, New York, United States; Stony Brook, New York, United States and 3 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.